AJU IB INVESTMENT

KOSDAQ-027360
KOSDAQ NYSE
Financials Investment - Banking & Investment Services
Global Rank
#19436
Country Rank
#618
Market Cap
216.83 M
Price
1.83
Change (%)
1.01%
Volume
871,330

AJU IB INVESTMENT's latest marketcap:

216.83 M

As of 06/09/2025, AJU IB INVESTMENT's market capitalization has reached $216.83 M. According to our data, AJU IB INVESTMENT is the 19436th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 216.83 M
Revenue (ttm) 39.94 M
Net Income (ttm) 6.08 M
Shares Out 118.41 M
EPS (ttm) 0.05
Forward PE 0.00
Ex-Dividend Date 12/27/2024
Earnings Date n/a
Market Cap Chart
Data Updated: 06/09/2025

AJU IB INVESTMENT's yearly market capitalization.

AJU IB INVESTMENT has seen its market value drop from ₩459.67 B to ₩296.62 B since 2020, representing a total decrease of 35.47% and an annual compound decline rate (CAGR) of 9.39%.
Date Market Cap Change (%)
06/09/2025 ₩296.62 B 3.09%
12/30/2024 ₩287.74 B -11.56%
12/28/2023 ₩325.35 B 24.54%
12/29/2022 ₩261.24 B -44.19%
12/30/2021 ₩468.05 B 1.82%
12/30/2020 ₩459.67 B

Company Profile

About AJU IB INVESTMENT Co., Ltd.

AJU IB INVESTMENT Co., Ltd. is the venture capital and private equity division of AJU Corporation Co., Ltd. The firm specializes in investments across various sectors, focusing on small to medium-sized start-up companies in South Korea.

Investment Focus

  • Venture Capital: High-technology sectors, including IT, mobile service platforms, software, semiconductors, and biotech.
  • Private Equity: Manufacturing sector, corporate restructuring, and buyouts.
  • Additional Sectors: Life sciences, environmental technologies, immune system platforms, oncology drugs, and ophthalmic drugs.
  • Emerging Technologies: IoT, artificial intelligence, smart cars, and advanced materials.

International Investments

The firm's Boston, Massachusetts office focuses on:

  • Therapeutics addressing unmet medical needs.
  • Platform technologies with maturing lead candidates.
  • Partnership opportunities with Korean pharmaceutical companies.
  • Medical devices and diagnostics.

Exit Strategy

AJU IB INVESTMENT typically exits investments through:

  • Initial Public Offerings (IPOs).
  • Mergers and Acquisitions (M&A).

Company Background

Founded in 1974 as Kibo Technology Advancing Capital Co., the firm is headquartered in Seoul, South Korea, with additional offices in Boston, Massachusetts, and San Francisco, California.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.